Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. (Q44884460)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. |
scientific article |
Statements
1 reference
Pharmacoeconomic evaluation of testing for angiotensin-converting enzyme genotype before starting beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor therapy in men. (English)
1 reference
Cornelia M van Duijn
1 reference
Albert Hofman
1 reference
Jacqueline C M Witteman
1 reference
John J P Kastelein
1 reference
Anke Hilse Maitland-van der Zee
1 reference
Olaf H Klungel
1 reference
Bruno H Ch Stricker
1 reference
David L Veenstra
1 reference
Hubertus G M Leufkens
1 reference
Anthonius de Boer
1 reference
1 January 2004
1 reference
1 reference
14
1 reference
1
1 reference
53-60
1 reference
Identifiers
1 reference
1 reference